QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 4-biotech-stocks-seeing-explosive-momentum-gains

The SPDR S&P Biotech ETF (ARCA:XBI) is up more than 40% over the past six months and is on the verge of breaking out. Here...

Core News & Articles

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

Core News & Articles

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

 applied-therapeutics-meets-with-fda-on-potential-drug-filing-for-rare-nerve-disease-cmt-sord

Applied Therapeutics, Inc. (NASDAQ: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating trans...

Core News & Articles

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

Core News & Articles

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...

 applied-therapeutics-q2-eps-015-beats-016-estimate

Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of ...

 reported-sunday-applied-therapeutics-reports-24-month-data-from-inspire-trial-showing-govorestat-slows-disease-progression-in-cmt-sord-reinforces-plans-for-2025-nda

 Slowing of progression of disease observed via MRI at 24 monthsImprovements in outcomes and reduction in sorbitol maintained t...

 rbc-capital-reiterates-sector-perform-on-applied-therapeutics-maintains-15-price-target

RBC Capital analyst Brian Abrahams reiterates Applied Therapeutics (NASDAQ:APLT) with a Sector Perform and maintains $1.5 pr...

 applied-therapeutics-fy-2024-gaap-eps-076-beats-137-estimate

Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of ...

 william-blair-downgrades-applied-therapeutics-to-market-perform

William Blair analyst Sami Corwin downgrades Applied Therapeutics (NASDAQ:APLT) from Outperform to Market Perform.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION